|
Status |
Public on Dec 16, 2011 |
Title |
MDS, 5q- Syndrome |
Sample type |
genomic |
|
|
Source name |
untreated patient at diagnosis
|
Organism |
Homo sapiens |
Characteristics |
disease: MDS, 5q- Syndrome tissue: bone marrow genotype: small 12p deletions
|
Treatment protocol |
none; samples were obtained from untreated patients at diagnosis
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Qiagen DNA extraction kit (QIAamp DNA Mini Kit; 51306); elution buffer was 10mM Tris, 0.1mM EDTA, pH 8.0
|
Label |
Biotin
|
Label protocol |
according to the standard Affymetrix SNP 6.0 method protocol
|
|
|
Hybridization protocol |
according to the standard Affymetrix SNP 6.0 method protocol
|
Scan protocol |
according to the standard Affymetrix SNP 6.0 method protocol
|
Data processing |
Using Genotyping Console version 3.0.1 (Affymetrix) according to the default settings for the "Copy Number / LOH Configuration" except for "Smoothing Gaussian Window". It was set to 5000 instead of 50000 and the "Smooth Log2 ratio" was selected instead of "Calibrate Smooth Log2 ratio to CN".
|
|
|
Submission date |
Mar 08, 2011 |
Last update date |
Dec 16, 2011 |
Contact name |
Hans-Ulrich Klein |
E-mail(s) |
h.klein@uni-muenster.de
|
Organization name |
Columbia University Medical Center
|
Department |
Neurology
|
Lab |
Center for Translational and Computational Neuroimmunology
|
Street address |
622 W 168th St
|
City |
New York |
State/province |
NY |
ZIP/Postal code |
10032 |
Country |
USA |
|
|
Platform ID |
GPL6801 |
Series (1) |
GSE27832 |
CDKN1B encoding the cyclin-dependent kinase inhibitor 1B (p27) is located in the minimally deleted region of 12p abnormalities in myeloid malignancies and its low expression is a favorable prognostic marker in acute myeloid leukemia |
|